COBAS AMPLIPREP/COBAS TAQMAN HIV-1 TEST 03542998190

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 06 report with the FDA on 2009-03-26 for COBAS AMPLIPREP/COBAS TAQMAN HIV-1 TEST 03542998190 manufactured by Roche Molecular Systems.

Event Text Entries

[1055865] The customer alleged (b)(4) for a patient with the cobas ampliprep/cobas taqman hiv-1test.
Patient Sequence No: 1, Text Type: D, B5


[8259266] Method evaluation to include sequence analysis of specimen. There is no evidence of product malfunction at this time. Reliable results are dependent upon adequate specimen collection, transport, storage and processing procedures. It is also possible that rare mutations within the highly conserved region of the viral genome covered by the test's primers and/or probe may result in the underquantitation of or failure to detect the virus. Results from the cobas ampliprep/cobas taqman hiv-1 test should be interpretted with consideration of all clinical and laboratory findings. Due to inherent differences between technologies, it is recommended that, prior to switching from one technology to the next; users perform method correlation studies in their laboratory to quantify differences. (b)(4).
Patient Sequence No: 1, Text Type: N, H10


[20825978] Internal evaluation confirmed the customer allegations. Based on the sequencing results, it is likely that the cobas ampliprep/cobas taqman test underquantitated the viral load in the result under question for one patient. The procedural limitations section of the package insert contains the following applicable statements. "though rare, mutations within the highly conserved region of the viral genome covered by the cobas ampliprep/cobas taqman test primers and/or probe may result in the underquantitation of or failure to detect the virus. " "due to inherent differences between technologies, it is recommended that, prior to switching from one technology to the next, users perform correlation studies in their laboratory to quantify technology differences. " the cobas ampliprep/cobas taqman test is intended to be used as a monitoring assay and as such, it is unlikely that a physician would change a patient's treatment based on a single data point. A patient's history and clinical manifestations would be considered before changes to treatment were made. It is concluded there was no likely risk to the patient and would not result in serious injury or death in this case. A second generation of the test has been developed that includes amplification and detection of a second region (the ltr region in addition to the gag gene of the viral genome) which will reduce incidents of underquantitation of or failure to detect the virus due to mutations. Submission of a supplement pma is anticipated for mid 2009.
Patient Sequence No: 1, Text Type: N, H10


[20835853] The customer alleged underquantitated results for a patient with the cobas ampliprep/cobas taqman test.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number2243471-2009-00006
MDR Report Key1351264
Report Source06
Date Received2009-03-26
Date of Report2009-05-08
Date of Event2008-04-08
Date Mfgr Received2009-03-03
Date Added to Maude2010-03-03
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Reporter OccupationMEDICAL TECHNOLOGIST
Health Professional3
Initial Report to FDA3
Report to FDA0
Event Location0
Manufacturer ContactMR. ROBERT PIGOZZI
Manufacturer Street4300 HACIENDA DRIVE
Manufacturer CityPLEASANTON CA 945880900
Manufacturer CountryUS
Manufacturer Postal945880900
Manufacturer Phone9257308272
Manufacturer G1ROCHE MOLECULAR SYSTEMS
Manufacturer Street1080 US HWY 202
Manufacturer CitySOMERVILLE NJ 08876377
Manufacturer CountryUS
Manufacturer Postal Code08876 3771
Single Use3
Remedial ActionOT
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameCOBAS AMPLIPREP/COBAS TAQMAN HIV-1 TEST
Generic NameMONITOR TEST, HIV-1
Product CodeMTL
Date Received2009-03-26
Catalog Number03542998190
Lot NumberK04584
Device Expiration Date2009-03-31
OperatorMEDICAL TECHNOLOGIST
Device AgeDA
Device Eval'ed by MfgrY
Device Sequence No1
Device Event Key0
ManufacturerROCHE MOLECULAR SYSTEMS
Manufacturer Address1080 US HWY 202 SOMERVILLE NJ 08876377 US 08876 3771


Patients

Patient NumberTreatmentOutcomeDate
10 2009-03-26

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.